Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$7.33 - $9.39 $771,914 - $988,851
-105,309 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$7.9 - $10.19 $19,797 - $25,536
2,506 Added 2.44%
105,309 $844,000
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $21,651 - $25,281
2,187 Added 2.17%
102,803 $1.02 Million
Q4 2020

Feb 08, 2021

BUY
$8.61 - $11.04 $809 - $1,037
94 Added 0.09%
100,616 $971,000
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $10,446 - $15,469
1,219 Added 1.23%
100,522 $906,000
Q2 2020

Aug 11, 2020

BUY
$8.12 - $13.12 $27,258 - $44,043
3,357 Added 3.5%
99,303 $1.22 Million
Q1 2020

May 08, 2020

BUY
$6.69 - $13.45 $9,165 - $18,426
1,370 Added 1.45%
95,946 $862,000
Q4 2019

Feb 12, 2020

BUY
$6.53 - $10.72 $5,465 - $8,972
837 Added 0.89%
94,576 $927,000
Q3 2019

Nov 12, 2019

BUY
$6.16 - $9.6 $11,346 - $17,683
1,842 Added 2.0%
93,739 $645,000
Q2 2019

Jul 30, 2019

BUY
$8.12 - $15.72 $13,576 - $26,283
1,672 Added 1.85%
91,897 $848,000
Q1 2019

May 10, 2019

BUY
$15.58 - $20.01 $465,904 - $598,379
29,904 Added 49.57%
90,225 $1.42 Million
Q4 2018

Feb 08, 2019

BUY
$14.59 - $23.84 $21,272 - $34,758
1,458 Added 2.48%
60,321 $930,000
Q3 2018

Nov 07, 2018

BUY
$21.06 - $25.65 $407,742 - $496,609
19,361 Added 49.01%
58,863 $1.27 Million
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $15,361 - $22,634
916 Added 2.37%
39,502 $961,000
Q1 2018

May 04, 2018

BUY
$16.68 - $22.07 $11,792 - $15,603
707 Added 1.87%
38,586 $659,000
Q4 2017

Feb 07, 2018

BUY
$11.23 - $19.1 $11,488 - $19,539
1,023 Added 2.78%
37,879 $718,000
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $567,950 - $1.19 Million
36,856
36,856 $649,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Agf Investments America Inc. Portfolio

Follow Agf Investments America Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments America Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments America Inc. with notifications on news.